EX-23.1 CONSENT OF GRANT THORNTON LLP
Published on June 13, 2005
EXHIBIT 23.1
CONSENT OF REGISTERED INDEPENDENT PUBLIC ACCOUNTING FIRM
We have issued our report dated March 31, 2005, accompanying the consolidated
financial statements of Access Pharmaceuticals, Inc. contained in
the Registration Statement and Prospectus. We have also issued our report dated
March 31, 2005, on management's assessment of the effectiveness of internal
control over financial reporting included in the Annual Report on Form 10-K for
the year ended December 31, 2004. We consent to the use of the aforementioned
reports in the Registration Statement and Prospectus, and to the use of our
name as it appears under the caption "Experts."
/s/ Grant Thornton LLP
Grant Thornton LLP
Dallas, Texas
June 10, 2005